Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics.

Manaka MuneishiAyaka NakamuraKatsumi TachibanaJunko SuemitsuShinji HasebeKazuto TakeuchiYoshihiro Yakushijin

Published in: International journal of clinical oncology (2017)

R monotherapy for patients whose diseases show low tumor burden and who are not candidates for local treatment has benefits as a first-line treatment compared to R-CHOP, based on the patients' QOL and medical economics.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
healthcare
chronic kidney disease
peritoneal dialysis
randomized controlled trial
clinical trial
adipose tissue
risk factors
skeletal muscle
patient reported outcomes
diffuse large b cell lymphoma
study protocol
double blind